As of December 13 at 4:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
54,370.00
54,370.00
44,388.00
50,272.00
40,754.00
Operating Income
-54,370.00
-54,370.00
-44,388.00
-50,272.00
-40,754.00
Net Non Operating Interest Income Expense
603.00
603.00
338.00
384.00
-3,524.00
Other Income Expense
-118,824.00
-118,824.00
-196,760.00
-44,908.00
-30,627.00
Pretax Income
-172,591.00
-172,591.00
-240,810.00
-94,796.00
-74,905.00
Tax Provision
10.00
10.00
1.00
1.00
-85.00
Net Income Common Stockholders
-172,601.00
-172,601.00
-240,811.00
-94,797.00
-74,820.00
Diluted NI Available to Com Stockholders
-172,601.00
-172,601.00
-240,811.00
-94,797.00
-74,820.00
Basic EPS
-2.32
-2.32
-2.77
-1.09
-0.86
Diluted EPS
-2.32
-2.32
-2.77
-1.09
-0.86
Basic Average Shares
74,411.00
74,411.00
86,795.84
86,795.84
86,795.84
Diluted Average Shares
74,411.00
74,411.00
86,795.84
86,795.84
86,795.84
Total Expenses
54,370.00
54,370.00
44,388.00
50,272.00
40,754.00
Net Income from Continuing & Discontinued Operation
-172,601.00
-172,601.00
-240,811.00
-94,797.00
-74,820.00
Normalized Income
-174,190.48
-174,190.48
-240,411.26
-92,634.74
-74,072.85
Interest Income
753.00
753.00
431.00
467.00
330.00
Interest Expense
150.00
150.00
93.00
83.00
72.00
Net Interest Income
603.00
603.00
338.00
384.00
-3,524.00
EBIT
-172,441.00
-172,441.00
-240,717.00
-94,713.00
-74,833.00
EBITDA
-171,772.00
-171,772.00
-239,942.00
-94,032.00
-74,224.00
Reconciled Depreciation
669.00
669.00
775.00
681.00
609.00
Net Income from Continuing Operation Net Minority Interest
-172,601.00
-172,601.00
-240,811.00
-94,797.00
-74,820.00
Total Unusual Items Excluding Goodwill
2,012.00
2,012.00
-506.00
-2,962.00
-748.00
Total Unusual Items
2,012.00
2,012.00
-506.00
-2,962.00
-748.00
Normalized EBITDA
-173,784.00
-173,784.00
-239,436.00
-91,070.00
-73,476.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
422.52
422.52
-106.26
-799.74
-0.85
12/31/2020 - 11/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HCWB HCW Biologics Inc.
0.3564
-0.17%
LSB LakeShore Biopharma Co., Ltd
2.5900
+9.00%
CDT Conduit Pharmaceuticals Inc.
0.0758
-7.00%
RADX Radiopharm Theranostics Limited
5.63
-2.93%
SLXN Silexion Therapeutics Corp
3.3500
-4.81%
ELAB Elevai Labs Inc.
2.1500
-6.11%
PBM Psyence Biomedical Ltd.
1.8400
-0.54%
CERO CERo Therapeutics Holdings, Inc.
0.0554
-2.29%
JUNS Jupiter Neurosciences, Inc.
13.04
+6.82%
MTEM Molecular Templates, Inc.
0.3851
-2.01%